Study on vaccine efficacy against Delta plus variant is underway: ICMR

Study on vaccine efficacy against Delta plus variant is underway: ICMR

Topics
Coronavirus | Coronavirus Tests | Coronavirus Vaccine

ANI 

Coronavirus vaccine
Photo: Bloomberg

 

New Delhi [India], June 26 (ANI): A study on the effectiveness of the existing COVID-19 vaccine against the Delta Plus variant, which has been notified as a "variant of concern" following its detection in several parts of India, is underway, said Dr Samiran Panda, Head of Epidemiology, ICMR on Saturday.

Amid concerns over COVID-19 third wave, the epidemiologist said the third wave will not be as severe as the second wave, which had ravaged the country in April-May and stretched healthcare infrastructure.

Suggesting that there is no need to panic, he asserted on the need for scaling up vaccination drive and COVID appropriate behaviour to mitigate many such future waves of the pandemic.

"The third wave of COVID-19 won't be as severe as the second wave. More vaccination and COVID-19 appropriate behaviour could play an important role in mitigating these waves. A study on vaccine effectiveness on Delta Plus variant of COVID-19 is underway," Panda told ANI here.

"So far, only 49 cases of Delta Plus variant have been reported from 10 states. This doesn't indicate that the third wave of COVID-19 has begun and calling it the onset of the third wave would be misleading," he added.

The third wave of the COVID-19 may not be as severe as the second wave, and scaling up the vaccination drive may help mitigate it, said a study conducted by the Indian Council of Medical Research in collaboration with Imperial College of London.

The authors of the study include Balram Bhargava, Director General, ICMR, and Samiran Panda, Head, Infectious Disease Unit, ICMR.

The study, based on mathematical modelling analysis, showed that the new variant is unlikely to cause a new wave unless it leads to a complete loss of immune protection from the previous infection.

A more transmissible variant would have to cross the reproduction number threshold of 4.5 to cause a third wave, said the study.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus
First Published: Sat, June 26 2021. 19:46 IST
RECOMMENDED FOR YOU